What is Atara Biotherapeutics, Inc's Market Cap?

Atara Biotherapeutics, Inc's Market Cap is $86.2M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Enterprise Value?

Atara Biotherapeutics, Inc's Enterprise Value is $76.4M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Price / Sales?

Atara Biotherapeutics, Inc's Price / Sales is 13.9×, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EV / Revenue?

Atara Biotherapeutics, Inc's EV / Revenue is 12.3×, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EV / EBITDA?

Atara Biotherapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Revenue (TTM)?

Atara Biotherapeutics, Inc's Revenue (TTM) is $6.2M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Net Income (TTM)?

Atara Biotherapeutics, Inc's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EBITDA?

Atara Biotherapeutics, Inc's EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's Diluted EPS (TTM)?

Atara Biotherapeutics, Inc's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.

What is Atara Biotherapeutics, Inc's EBITDA Margin?

Atara Biotherapeutics, Inc's EBITDA Margin is -227.6%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Atara Biotherapeutics, Inc

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG005Q3MR36

8.59▼ 0.84 (-8.91%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 9.43
Day's Range: 8.55 – 9.37
52-Week Range: 3.92 – 19.15
Volume: 24.3K
Avg Volume: 37.2K

Share Statistics

Shares Outstanding
Employees: 14
Exchange: XNAS
Listed: 2014-10-16

Share count as of August 10, 2026

Atara Biotherapeutics, Inc (ATRA) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Atara Biotherapeutics, Inc (ATRA)

What is Atara Biotherapeutics, Inc's Market Cap?: Atara Biotherapeutics, Inc's Market Cap is $86.2M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Enterprise Value?: Atara Biotherapeutics, Inc's Enterprise Value is $76.4M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Price / Sales?: Atara Biotherapeutics, Inc's Price / Sales is 13.9×, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EV / Revenue?: Atara Biotherapeutics, Inc's EV / Revenue is 12.3×, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EV / EBITDA?: Atara Biotherapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Revenue (TTM)?: Atara Biotherapeutics, Inc's Revenue (TTM) is $6.2M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Net Income (TTM)?: Atara Biotherapeutics, Inc's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EBITDA?: Atara Biotherapeutics, Inc's EBITDA is -$14.1M, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's Diluted EPS (TTM)?: Atara Biotherapeutics, Inc's Diluted EPS (TTM) is -1.66, based on as-reported figures from SEC (XBRL) filings.
What is Atara Biotherapeutics, Inc's EBITDA Margin?: Atara Biotherapeutics, Inc's EBITDA Margin is -227.6%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ATRAAs-filed SEC (XBRL) data